Ipv (Inactivated Polio Vaccine) Suppliers & Bulk Manufacturers
Available Forms: Injectable suspension (IM administration), Pre-filled syringes
Available Strengths: 0.5 mL
Reference Brands: IPOL(US)
Category:
Vaccines
IPV (Inactivated Polio Vaccine) stimulates immunity by introducing inactivated poliovirus to produce antibodies. It prevents poliovirus infection, helping eradicate the disease. Benefits include lifelong protection, safety for all ages, and effective community immunity, significantly reducing polio transmission and associated disabilities worldwide.
IPV (Inactivated Polio Vaccine) is available in Injectable suspension (IM administration), Pre-filled syringes
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, IPV (Inactivated Polio Vaccine) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
IPV (Inactivated Polio Vaccine) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
IPV (Inactivated Polio Vaccine) is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves rigorous clinical evaluation and safety data submission. In the EU, CE marking certifies conformity with in vitro diagnostic and pharmaceutical regulations. These vaccines undergo validation, stability testing, and comprehensive audits, with detailed documentation including safety profiles, clinical performance data, and manufacturing details. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective IPV formulations critical for global polio eradication efforts.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing